Armistice Capital »

Archrock shares owned by Armistice Capital

Quarter-by-quarter ownership of Archrock (AROC) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Archrock

Tip: Access up to 7 years of quarterly data

All positions including Archrock held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Archrock by Armistice Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.3M 88k 26.31

More positions owned by Armistice Capital

Iwm Nov5 230.0 P Listed Option Put Option (IWM)
Spy Nov5 634.0 P Listed Option Put Option (SPY)
Ptc Therapeutics Ord Equity (PTCT)
Travere Therapeutics Ord Equity (TVTX)
Supernus Pharmaceuticals Ord Equity (SUPN)
Cytk Jan7 40.0 C Listed Option Call Option (CYTK)
Madrigal Pharmaceuticals Ord Equity (MDGL)
Incyte Ord Equity (INCY)
Neurocrine Biosciences Ord Equity (NBIX)
Immunovant Ord Equity (IMVT)
Dentsply Sirona Ord Equity (XRAY)
Regeneron Pharmaceuticals Ord Equity (REGN)
Freshpet Ord Equity (FRPT)
Amazon Com Ord Equity (AMZN)
Agio Dec5 40.0 C Listed Option Call Option (AGIO)

View all positions for Armistice Capital

Top funds holding Archrock

BlackRock
Vanguard Group
Earnest Partners
Invesco
State Street Corporation
Dimensional Fund Advisors
American Century Companies
Sei Investments
Geode Capital Management
FMR
Goldman Sachs Group
Citadel Advisors
Morgan Stanley
Charles Schwab Investment Management
Millennium Management

View all funds holding Archrock